Lexicon Pharma (LXRX) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	38.77M
Short-term investments, including restricted investments of $430	356.78M
Accounts receivable, net of allowances of $35	738K
Prepaid expenses and other current assets	2.44M
Total current assets	398.74M
Property and equipment, net of accumulated depreciation and amortization of $78,680 and $80,323, respectively	19.85M
Goodwill	44.54M
Other intangible assets	53.36M
Other assets	454K
Total assets	516.95M
Accounts payable	41.55M
Accrued liabilities	32.91M
Current portion of deferred revenue	78.87M
Current portion of long-term debt	16.79M
Total current liabilities	170.11M
Deferred revenue, net of current portion	55.44M
Long-term debt	85.04M
Deferred tax liabilities	18.68M
Other long-term liabilities	2.5M
Total liabilities	331.76M
Commitments and contingencies	0
Preferred stock, $.01 par value; 5,000 shares authorized; no shares issued and outstanding	0
Common stock, $.001 par value; 900,000 shares authorized; 337,895 and 337,566 shares issued, respectively	104K
Additional paid-in capital	1.41B
Accumulated deficit	-1.22B
Accumulated other comprehensive gain	78K
Treasury stock, at cost, 218 and 158 shares, respectively	-3.37M
Total equity	185.18M
Total liabilities and equity	516.95M

Entities mentioned with LXRX

View All Entities